tirzepatide side effects hair loss Mounjaro (tirzepatide) is a prescription medication used for type 2 diabetes and increasingly for weight loss. It works by mimicking two natural hormones — GLP-1 and GIP — which reduce appetite and Does Mounjaro Cause Hair Loss?

Its prevalence has increased from 30.5% in 1999 to 2000 to 41.9% in 2017 to March 2020

Symptoms such as nausea, vomiting, diarrhea, constipation, and stomach pain are frequently reported, especially during the early stages of treatment

(Joint Advisory, 2025) The WHO's 2025 guideline on GLP-1 therapies for adult obesity says the same thing in plainer language: personalized, periodic monitoring of treatment response and adverse events is essential for sustained outcomes

As prices correct in India, the addressable market could expand significantly, especially in urban centres, said Rajesh Pherwani, Founder and Chief Investment Officer at Valcreate Investment Managers LLP

bmiMD uses standard injectable protocols

Only three identified real-world studies have evaluated weight loss among patients with overweight or obesity who were treated with both semaglutide and tirzepatide, but differences in populations, follow-up time, and study design limit comparisons